RSW Renishaw plc
Renishaw plc, an engineering and scientific technology company, designs, manufactures, distributes, sells, and services technological products and services, and analytical instruments and medical devices worldwide. The company operates through three segments: Industrial Metrology, Position Measurement, and Specialised Technologies. It offers precision measurement and process control products, such as co-ordinate measuring machine probes, software, retrofits, equator gauging systems, fixtures, machine calibration and optimization, machine tool probes, precision styli for metrology, and smart manufacturing data platform; and position and motion control products comprising interferometric laser, magnetic, and optical encoders. The company also provides healthcare products, such as neuromate stereotactic robots, neuroinfuse drug delivery systems, neuroinspire surgical planning software, dixi medical's, and Raman spectrometers; industrial robots; and metal additive 3D printing manufacturing systems. It serves the aerospace, automotive, consumer electronics, medical and healthcare, heavy, machine builder, energy, and precision manufacturing industries, as well as scientific, research, and analysis industries. The company was incorporated in 1973 and is based in Wotton-under-Edge, the United Kingdom.…
Industry Peers
Scientific & Technical InstrumentsKey Statistics
About Renishaw (LON: RSW)
›
Renishaw (LON: RSW) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Scientific & Technical Instruments industry, part of the Technology sector, and reports about 5,254 employees.
The shares were at 4622.00 GBp on 20 November 2026, up 34.9% over 52 weeks. Its 52-week range is 3280.00 GBp to 6030.00 GBp: the price is 23.3% below the high and 40.9% above the low.
At a market capitalisation of 3.45B GBP, it trades at 29.1 times trailing earnings and 17.2 times forward earnings. The median trailing P/E of its 19 largest Scientific & Technical Instruments peers is 31.0, so RSW is valued in line with them. It pays a dividend yielding 1.75% (it pays out 48% of its earnings), against a median of 0.95% among the dividend payers in that peer group.
Renishaw reports return on equity of 12.1%, an operating margin of 19.0% and revenue up 21.1% year over year.
It holds more cash than debt, a net cash position of 277.45M GBP. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health. 8 analysts cover the stock, with an average rating of Buy; their mean price target of 6372.50 GBp is 37.9% above the current price. The next earnings report is expected on 9 February 2027.